Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
Public ClinicalTrials.gov record NCT05609812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter, Multinational Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Active Lupus Nephritis
Study identification
- NCT ID
- NCT05609812
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vera Therapeutics, Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Atacicept Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2022
- Primary completion
- Mar 14, 2026
- Completion
- Dec 14, 2028
- Last update posted
- May 22, 2025
2022 – 2028
United States locations
- U.S. sites
- 26
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vera Site # 0139 | Huntsville | Alabama | 35805 | — |
| Vera Site # 0138 | La Jolla | California | 92037 | — |
| Vera Site # 0127 | La Palma | California | 90623 | — |
| Vera Site # 0129 | Long Beach | California | 90822 | — |
| Vera Site # 0135 | Northridge | California | 91324 | — |
| Vera Site # 0136 | Northridge | California | 91324 | — |
| Vera Site # 0130 | Santa Clarita | California | 91321 | — |
| Vera Site # 0131 | Torrance | California | 90502 | — |
| Vera Site # 0143 | New Haven | Connecticut | 06520 | — |
| Vera Site # 0140 | Gainesville | Florida | 32610 | — |
| Vera Site # 0128 | Miami | Florida | 33125 | — |
| Vera Site # 0134 | Atlanta | Georgia | 30309 | — |
| Vera Site # 0137 | Augusta | Georgia | 30912 | — |
| Vera Site # 0144 | Augusta | Georgia | 30912 | — |
| Vera Site # 0147 | Lawrenceville | Georgia | 30046 | — |
| Vera Site # 0109 | Chicago | Illinois | 60611 | — |
| Vera Site # 0133 | Las Vegas | Nevada | 89106 | — |
| Vera Site # 0149 | Summit | New Jersey | 07901 | — |
| Vera Site # 0146 | New York | New York | 10016 | — |
| Vera Site # 0142 | New York | New York | 10039 | — |
| Vera Site # 0148 | Cleveland | Ohio | 44109 | — |
| Vera Site # 0145 | Columbus | Ohio | 43210 | — |
| Vera SIte # 0132 | Jackson | Tennessee | 38305 | — |
| Vera Site # 0125 | Dallas | Texas | 75231 | — |
| Vera Site # 0126 | Dallas | Texas | 75231 | — |
| Vera Site # 0122 | El Paso | Texas | 79925 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05609812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05609812 live on ClinicalTrials.gov.